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Extrapulmonary small-cell carcinoma (EPSCC) is a rare small-cell carcinoma (SCC). It is recognized as
a clinicopathological entity distinct from SCCs of the tracheobronchial tree. EPSCCs account for about
2.5% of all SCCs. SCCs of the kidney are an even rarer neoplasm. Abdominal pain and hematuria are the
major clinical symptoms. Many cases are already advanced disease at diagnosis and have poor prognoses.
Platinum-based chemotherapy seems to be beneﬁcial for overall survival. We describe an 82-year-old
male patient who was seen at the emergency room due to complaints of gross hematuria and right-ﬂank
pain. Computed tomography showed a large right renal tumor. Treatment modalities, pathologic
features, survival outcome of this case, and a review of similar cases in the literature are presented and
discussed. To the best of our knowledge, this is the 21st case of SCC of the kidney reported in the liter-
ature to date. It is also the ﬁrst report in Taiwan of a primary SCC of the kidney with the tumor thrombus
extending to the inferior vena cava which required a right radical nephrectomy.
Copyright  2011, Taiwan Urological Association. Published by Elsevier Taiwan LLC.
Open access under CC BY-NC-ND license.1. Introduction
Extrapulmonary small-cell carcinoma (EPSCC), although a rare
neoplasm, is now being increasingly reported. EPSCC was ﬁrst
described in 1930 by Duguid and Kennedy.1 It accounts for about
2.5% of all small-cell carcinomas (SCCs).2 The primary site of
occurrencewas reported in a variety of organs, such as the head and
neck region, gastrointestinal tract, genitourinary tract, and oth-
ers.2e5 The most common site in the genitourinary tract is the
urinary bladder. Primary SCC of the kidney is an extremely rare
neoplasm with aggressive behavior. Many of these cases had
advanced disease at diagnosis and have a poor prognosis.We report
a case of SCC of the kidney and reviewed the literature on this rare
neoplasm.2. Case report
This 82-year-old male patient had good general health and
denied any previous systemic disease. He was a non-smoker. No
bodyweight loss had been noted in the past year. However, painless
gross hematuria had been noted for 1 year. In addition, he had
suffered from right-ﬂank and lower-abdominal-quadrant pain for
1 month. He visited the emergency room, where abdominaltment of Surgery, Shin Kong
, Shilin District, Taipei 111,
.
ciation. Published by Elsevier Taiwsonography revealed a right renal mass. Computed tomography
(CT) disclosed a heterogeneous contrast-enhanced mass occupying
the upper pole of the right kidney.
During admission, a physical examination revealed a right-ﬂank
mass. Urinalysis showed hemopyuria [red blood cell count >100/
high-power ﬁeld (HPF) and white blood cell count >100/HPF].
A hemogram showed mild anemia (hemoglobin of 10.3 g/dL). His
preoperative creatinine level was normal (1.2 mg/dL). No active
lung lesion was noted on a chest ﬁlm. Retrograde pyelography was
done, but the right renal pelvis could not be demonstrated due to
difﬁculty with the contrast medium entering this area. A CT scan
revealed a 7.3  6.0-cm heterogeneous contrast-enhanced mass in
the upper pole of the right kidney. A tumor thrombus in the inferior
vena cava and clusters of enlarged lymph nodes in the retrocaval
and para-aortocaval spaces and right renal hilum were also
demonstrated on the CT scan (Fig. 1). A whole-body bone scan
showed no evidence of bone metastasis.
Under the impression of a right renal tumor, he received
a transperitoneal laparoscopic radical nephrectomy. The operative
course was smooth with blood loss of about 50 mL. The operative
time was 4 hours. During the operation, multiple enlarged lymph
nodes were noted around the renal hilar area with severe adhesion
to the inferior renal cava. Complete lymph-node dissection was too
difﬁcult and too dangerous to perform. The pathology report
revealed SCC with angiolymphatic invasion. A tumor thrombus in
the renal vein was also noted. Histopathologic pictures showed
small, oval to spindle-shaped tumor cells. A higher magniﬁcation
revealed tumor cells with hyperchromatic nuclei and scantyan LLC. Open access under CC BY-NC-ND license.
Fig. 1. Computed tomography scan showing a 7.3  6.0-cm heterogeneous contrast-enhanced mass in the upper pole of the right kidney (left) with right para-aortic and retrocaval
lymph nodes and an inferior vena cava tumor thrombus (right).
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histochemical studies revealed positive reactivity for cytokeratin,
neuron-speciﬁc enolase (NSE), synaptophysin (Fig. 3), and chro-
mogranin A (Fig. 4). The ﬁnal pathologic stage was T3aN1M0, stage
IV. He received a Port-a-Cath (Smith Medical, PORT-A-CATH II Low
Proﬁle) implantation and was then referred to the oncology
department for further adjuvant chemotherapy. The patient
received four courses of chemotherapy with starting doses of
300 mg/m2 carboplatin and 75 mg/m2 etoposide. Unfortunately,
folloe-up CT revealed multiple nodal metastases in the para-
aortocaval space, peritoneal space, and bilateral common iliac
chain 4 months postoperatively. The general condition of the
patient graduallyworsened, and hewas referred to hospice care. He
died 9 months after the laparoscopic radical nephrectomy.
3. Discussion
EPSCC is a rare neoplasm. It accounts for approximately 2.5% of
all SCCs. The ﬁrst case report of an EPSEC that occurred in the
mediastinal gland was in 1930.1 In the US, the overall incidence of
EPSCC is estimated to be 0.1e0.4% of all cancers.6
EPSCC can occur in various organs including those of the
gastrointestinal and genitourinary tracts. The most common site ofFig. 2. Tumor cells with hyperchromatic nuclei, indistinct nucleoli, and scanty cyto-
plasm (hematoxylin and eosin stain; 400).occurrence in the genitourinary tract is the urinary bladder.3
Primary SCC of the kidney is an extremely rare disease. Only 20
cases of SCC of the kidney have been reported in the literature to
date.7 According to Majhail’s report, the medium age at diagnosis
was 62 years with a female predominance (male:female ratio of
1:3.4).2
Clinical symptoms of a renal SCC are indistinguishable from
those of a renal cell carcinoma. Abdominal pain and hematuria are
the most common clinical features.1e3 The behavior of this rare
neoplasm seems quite aggressive. Early dissemination and frequent
recurrence are common. About 32% of patients showed distant
metastasis at the time of diagnosis.1,3
Imaging studies, including chest X-ray, and chest and abdominal
CT scans, should be carried out, but it is still difﬁcult to distinguish
an SCC from a renal cell carcinoma. Magnetic resonance imaging of
an EPSCC shows a diminished signal on T1-weighted images and
a heterogeneous mixed signal on T2-weighted images. In addition,
the predominant medullary location and lack of central necrosis are
features of EPSCC, which are unusual for a renal cell carcinoma.8
A whole-body bone scan should also be done to detect early
dissemination.
The differential diagnosis of EPSCC includes renal cell carci-
noma, urothelial carcinoma, renal sarcomas, and other metastaticFig. 3. Immunohistochemical studies showing diffuse positive staining for synapto-
physin (original magniﬁcation, 400).
Fig. 4. Immunostaining showing diffuse positive staining for chromogranin A (original
magniﬁcation, 400).
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characteristics, such as the appearance of round to spindle-shaped
small cells with dense nuclei, inconspicuous nucleoli, and sparse
cytoplasm. For equivocal cases, immunohistochemical staining
with chromogranin A, synaptophysin, or NSE may be helpful.1,3
In the treatment of EPSCC, surgery alone is not enough. In
the published literature, a combination of surgical resection
and chemotherapy offered better results.1e3 Due to the local
extensiveness and early dissemination of this rare tumor,chemotherapy can be of some help. The combination of platinum-
based chemotherapy and etoposide, 5-ﬂuorouracil, or gemcitabine
may improve overall survival. The medium overall survival was 8
months in non-chemotherapy patients, and 20 months in patients
receiving platinum-based combination chemotherapy (p ¼ 0.02).1
In conclusion, SCC of the kidney is an extremely rare neoplasm
with aggressive behavior and a high propensity for locoregional
dissemination. The clinical presentation is usually late with a poor
prognosis. Combination chemotherapy with a platinum-based
regimen showed beneﬁts against tumor progression and for over-
all survival.References
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